This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: William Vernier: Innovator in Pharmaceutical Compounds
Introduction
William Vernier is a notable inventor based in San Bruno, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
William Vernier holds a patent for "Pyrido-pyrimidinone and pteridinone compounds and methods of use." This patent describes various pyrido-pyrimidinone and pteridinone compounds, including their stereoisomers, tautomers, and pharmaceutically acceptable salts. The patent outlines the structural features and substituents of these compounds, as well as their potential use in pharmaceutical compositions and medicaments aimed at treating cancer, both alone and in combination with other therapeutic agents. He has 1 patent to his name.
Career Highlights
William Vernier is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking research and the advancement of new therapeutic options for patients.
Collaborations
William has collaborated with esteemed colleagues, including Marie-Gabrielle Braun and Georgette M Castanedo. These collaborations have fostered a productive environment for innovation and have enhanced the development of new pharmaceutical solutions.
Conclusion
William Vernier's contributions to the field of pharmaceuticals, particularly through his patent on pyrido-pyrimidinone and pteridinone compounds, highlight his role as an innovator in cancer treatment. His work continues to impact the medical community positively.